Teva intros generic Diclegis

6/27/2019
Teva is introducing doxylamine succinate and pyridoxine hydrochloride delayed-release tablets in a dosage strength of 10/mg/10 mg.

The product is the generic of Duchesnay’s Diclegis (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets 10 mg/10 mg, and used to treat nausea and vomiting of pregnancy in women who have not improved with change in diet or other non-medicine treatments.

Teva's product is available in bottles of 100.
X
This ad will auto-close in 10 seconds